Intragenic Epigenetic Deregulation by IDH2 Mutations Synergizes with SRSF2 Mutations Causing Mis-splicing of Key Transcriptional Regulators [RNA-seq]
RNA-seq (gene expression) · human · 20 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 20 samples: 20 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulatorsScience advances · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE280581_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1179445 and SRA study SRP541817. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 11 samples read as cases, 3 as controls.
How we read this: Read from 20 sample titles: 20 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8601579 201T1B_IDH2-Mutant_SRSF2-WT RNA
- GSM8601580 225T15B_IDH2-WT_SRSF2-Mutant RNA
- GSM8601581 246T9B_IDH2-Mutant_SRSF2-WT RNA
- GSM8601582 247T2Ba_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601583 247T2Bb_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601584 283T9B_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601585 287T1M_IDH2-WT_SRSF2-Mutant RNA
- GSM8601586 475T1B_IDH2-WT_SRSF2-Mutant RNA
- GSM8601587 495T1M_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601588 523T2B_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601589 543T6B_IDH2-Mutant_SRSF2-WT RNA
- GSM8601590 54T1B_IDH2-WT_SRSF2-WT RNA
- GSM8601591 556T2B_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601592 560T3B_IDH2-WT_SRSF2-Mutant RNA
- GSM8601593 584T3M_IDH2-WT_SRSF2-Mutant RNA
- GSM8601594 587T2B_IDH2-WT_SRSF2-WT RNA
- GSM8601595 614T1M_IDH2-Mutant_SRSF2-Mutant RNA
- GSM8601596 648T1B_IDH2-Mutant_SRSF2-WT RNA
- GSM8601597 736T3b_IDH2-WT_SRSF2-Mutant RNA
- GSM8601598 85T1M_IDH2-WT_SRSF2-WT RNA
- GSE263299 Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition [RNA-seq] 10 samples shares mis-splicing, regulators
- GSE305480 Disease specific epigenetic deregulation of enhancers, transposons and polycomb targets in acute promyelocytic leukemia 6 samples shares deregulation, epigenetic
- GSE263300 Mis-splicing of mitotic regulators sensitizes SF3B1-mutated human HSCs to CHK1 inhibition [scRNA-seq] 2 samples shares mis-splicing, regulators
- GSE213002 ATR/CHK1/WEE1 dependency in SRSF2-mutated myeloid malignancies 16 samples shares srsf2
- GSE299161 MALNC: A new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response 15 samples shares idh2
- GSE261434 A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma [RNAseq_Enasidenib_L2975_SW1353] 12 samples shares idh2
- GSE242063 Effect on gene expression of knock down of Scrambled control or Kdm3b on wild-type or Idh2 R140Q TF-1 cells 9 samples shares idh2
- GSE300406 Effect of knock-down SRSF2 6 samples shares srsf2
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.